Microneedling as a delivery route, and as a confounder
Why microneedling is paired with topical preparations, what it does on its own, and why that makes attribution of results unusually difficult.
Microneedling creates an array of micro-channels through the epidermis into the upper dermis. It is used with topical preparations for one clear reason: it produces a temporary route past a barrier that would otherwise exclude large molecules and particles.
It is also a treatment in its own right, with its own body of evidence, that provokes a wound healing response. That dual role makes it the central methodological problem in this field. Any study of a substance applied after needling is a study of two interventions, and only a control arm receiving needling alone can tell you which one produced the result.
What the procedure does mechanically
A device drives fine needles into skin at a controlled depth, creating an array of channels. The channels close over a period of hours. During that window there is a physical route past the stratum corneum, and this is what makes topical application of large molecules conceivable at all, for the reasons in can a vesicle cross the skin barrier.
The same needle passes cause micro-injury. Injury initiates the wound healing sequence: an initial inflammatory phase, a proliferative phase involving fibroblast activity and matrix deposition, and a prolonged remodelling phase. That sequence is the basis of microneedling as a standalone treatment.
Two things at once
Consider a typical protocol: needling, followed immediately by application of a preparation, with assessment at intervals. Any improvement observed has at least three candidate causes.
- The needling, acting as a controlled injury that provokes matrix deposition.
- The preparation, delivered through the channels and acting on tissue.
- The occlusion and hydration provided by whatever the preparation is formulated in, applied to freshly injured skin.
The third is easy to overlook and not trivial: freshly needled skin is more permeable to everything, including the vehicle, and post-procedure hydration affects appearance in the days that follow, which is often when photographs are taken.
Applying a preparation after microneedling produces better results than microneedling alone.
- Proposed mechanism
- Micro-channels allow the preparation to reach viable tissue, where it acts on cells in addition to the healing response provoked by the needling.
- What has been shown
- Microneedling alone has a body of clinical evidence for texture and scarring indications. Studies of needling combined with topical preparations frequently report improvement, but a substantial share compare the combination against no treatment or against a different treatment, rather than against needling with an inert vehicle. Where a needling-plus-vehicle control is used, the interpretive burden shifts appropriately, and such designs are the minority.
- Highest level reached
- Small human studies
- Main confounders
- The needling itself as an effective intervention. Vehicle occlusion and hydration on permeable skin. Assessment timing overlapping with the resolution of procedural swelling. Unblinded assessment.
GradeEARLY, UNREPLICATED
What would change thisSplit-face or randomised designs comparing needling plus the test preparation against needling plus an identical vehicle without the active fraction, with blinded assessment at a time point beyond the resolution of procedural effects.
The split face design and its limits
The obvious solution is to treat one side of the face with the preparation and the other with a vehicle. This controls for the patient, which removes a large source of variability, and it is widely used in dermatology.
It has known limitations. Systemic effects would appear on both sides and be missed. Patients may handle the two sides differently. Assessors comparing two halves of one face may anchor on asymmetries that already existed. And in this field specifically, if the applied material has any effect beyond the treated area, the control side is not clean. None of these invalidates the design, and all of them should be reported. We discuss it further in controls, blinding and the split face design.
| Comparison | Answers | Does not answer |
|---|---|---|
| Needling plus preparation versus nothing | Whether the protocol does anything | Whether the preparation contributes |
| Needling plus preparation versus needling alone, no vehicle | Whether adding a topical step helps | Whether the active fraction or the vehicle helps |
| Needling plus preparation versus needling plus matched vehicle | Whether the active fraction contributes | Whether the effect persists beyond the study period |
| Preparation without needling versus vehicle without needling | Whether the preparation acts through intact skin | Anything about the combined protocol |
Depth, and what it changes
Needle depth is a protocol variable that changes both the delivery route and the injury dose. Shallower settings produce a milder response and shallower channels; deeper settings produce more injury and reach further. Studies that do not report depth have omitted a determinant of both mechanisms they are trying to distinguish.
Depth also bears on the regulatory question. A procedure that breaches skin is a different proposition from one that does not, and applying a substance into breached skin is arguably closer to administration than to topical use. That argument is set out in topical after microneedling is a different question, where we are careful to say what is settled and what is not.
Infection and sterility
Applying any preparation to freshly breached skin raises a sterility question that does not arise with intact skin. Whatever is applied has a route into tissue. This makes the manufacturing questions in sterility, endotoxin and cold chain directly relevant rather than academic, and it is a reasonable thing for a patient to ask about: what is the sterility status of the product being applied to my broken skin, and who verified it.
What microneedling deserves on its own terms
It would be easy to read this article as diminishing microneedling. The opposite is closer to our view. Microneedling has a clinical evidence base in its own right, a coherent mechanism, and a reasonable safety profile in trained hands. It is one of the better established treatments in this whole family.
That is exactly why it makes such a demanding control condition, and why so many studies avoid using it as one. When the control arm is itself an effective treatment, showing that your addition improves on it is hard. Difficulty is not an excuse for not running the comparison; it is the reason the comparison is informative.
Questions readers ask
Why is microneedling used with exosome preparations?
Because intact skin is a strong barrier to particles and large molecules, and needling creates temporary channels through it. Without barrier disruption there is no plausible route for material of that size to reach living tissue.
Does microneedling work on its own?
It has a body of clinical evidence for indications including texture and scarring, and a coherent mechanism based on controlled injury provoking a healing response. It is one of the better established treatments in this family.
Why does that make studies hard to interpret?
Because a study of a substance applied after needling is a study of two interventions. Only a control arm receiving needling with an inert vehicle can show whether the substance contributed.
What is a split face study?
A design in which one side of the face receives the test treatment and the other a control, so the patient acts as their own comparison. It controls for individual variation but has limits, including possible spread of effect and assessor anchoring on pre-existing asymmetry.
Is it safe to apply a product to freshly needled skin?
It creates a route into tissue for whatever is applied, which makes the sterility status of the product a direct clinical question rather than an academic one. It is reasonable to ask what the sterility status of the product is and who verified it.